Welcome from the Symposium President

Dear colleagues,

We are proud to invite you to join the Autumn Symposium of the European Society of Clinical Pharmacy in Krakow, Poland from 21-23 October 2024.

This year’s theme is ‘Implementing and scaling sustainable Clinical Pharmacy Practice’, centering on the key ESCP domains of Clinical Pharmacy Practice, Education and Research.

The Autumn Symposium in Krakow will provide a forum for clinical pharmacists, clinical pharmacy technicians, academics, researchers, students etc. to explore and share, and learn from, their innovations. The programme includes many keynote presentations from internationally renowned speakers, interactive workshops, oral and poster research presentations, networking opportunities, and much more.

The programme has been designed to be suitable for participants at all levels of clinical pharmacy expertise. There will be a focus on implementing, scaling and spreading and achieving the sustainability of innovations in clinical practice, all supported by new models of education and lifelong learning. This will be consistent with evidence generated both through robust, rigorous research and service evaluation relevant to all key stakeholders. Examples will cover the complete spectrum of health care settings in which clinical pharmacy is practiced with a key focus on patient centred approaches tailored to different patient populations, with models of care encompassing autonomous patient assessment and independent prescribing. The use of change management techniques, together with associated drivers and enablers, as well as those barriers which had to be overcome and lessons learnt will be highlighted. This will thus facilitate others to mirror and translate such best practice and integrate within routine care.

In the context of an ageing population, many of whom have multiple long term conditions, there is a need for appropriate polypharmacy and thus therapeutic advances in a number of such chronic conditions including cardiovascular and respiratory disease as well as diabetes and mental health, will also be central to the programme. This will apply similarly to antimicrobial agents and the problem of antimicrobial resistance. There will therefore be opportunities to showcase pharmacotherapy innovation but also in addition to highlight the ever growing potential of point of care diagnostics, pharmacogenomics and digital enablement, including data analytics, as they enhance and support best clinical pharmacy practice ESCP recognises the need to support the implementation of advanced clinical pharmacy practice by progressing education and training of current and future practitioners. Education is therefore a theme running throughout the Symposium, with keynote presentations relating to innovation in undergraduate, postgraduate and continuing professional development for all members of the clinical pharmacy team. There are opportunities to share and discuss new and innovative approaches to clinical pharmacy education, development, delivery, and evaluation.

Dissemination of research findings is central to the programme, with all abstracts published in the International Journal of Clinical Pharmacy. Oral and poster presentations are accepted in any field of clinical pharmacy practice, education, and research, with emphasis on sharing findings and experiences, leading to improved professional practice, patient care and outcomes.

The ESCP Symposium in Krakow is an excellent opportunity to enjoy discussions with international experts and fellow clinical pharmacists, clinical pharmacy technicians, academics, researchers, students etc. and share experience in one of the finest cities in Poland. Looking forward to meeting you in Krakow, Poland in Autumn 2024,


Kamila Urbańczyk MPharm, Poland

Symposium President

Committees and Committee Members

Organising Committee

Kamila Urbańczyk MPharm (Chair), Poland
Dr Thomas Kempen, ESCP treasurer, Netherlands
Dr Fatma Alraisi, ESCP Communication Committee, Oman
Dr Adrian Bryla, Poland
Anna Burton, ESCP IO, United Kingdom
Edwin van Aalten, PharmD, ESCP IO, Netherlands
Andrew Winterburn, United Kingdom

Scientific Committee

Prof Michael Scott (Chair), United Kingdom
Prof Betul Okuyan, Turkey
Prof Anna Wiela-Hojenska, Poland
Prof Derek Stewart, Qatar/United Kingdom
Prof Przemysław Kardas, Poland
Dr Robert Kowalski, Poland